Merck
MRK
#59
Rank
$252.00 B
Marketcap
$100.89
Share price
-1.35%
Change (1 day)
2.20%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): $7.59

According to Merck's latest financial reports the company's current EPS (TTM) is $7.59. In 2024 the company made an earnings per share (EPS) of $6.76 an increase over its 2023 EPS that were of $0.15.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$7.5912.35%
2024$6.764308.46%
2023$0.15-97.32%
2022$5.7310.92%
2021$5.1784.68%
2020$2.80-27.2%
2019$3.8463.44%
2018$2.35151.11%
2017$0.94-54.58%
2016$2.0630.21%
2015$1.58-61.99%
2014$4.16180.51%
2013$1.48-31.82%
2012$2.186.62%
2011$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.72-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$10.44 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$20.52 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$2.97-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$3.71-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$3.60-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.63-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$7.36-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
$8.06 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$13.03 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA